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Abstract
Magnetic resonance imaging (MRI) has great potential to improve prostate cancer diag-
nosis. It can spare men with a normal exam from undergoing invasive biopsy while making
biopsies more accurate in men with lesions suspicious for cancer. Yet, the subtle differences
between cancer and confounding conditions, render the interpretation of MRI challenging. The
tissue collected from patients that undergo pre-surgical MRI and radical prostatectomy pro-
vides a unique opportunity to correlate histopathology images of the entire prostate with MRI
in order to accurately map the extent of prostate cancer onto MRI. Such mapping will help
improve existing MRI interpretation schemes, e.g. PIRADS, and will facilitate the development
of quantitative image analysis methods to assess the imaging characteristics of prostate cancer
on MRI. Here, we introduce the RAPSODI (RAdiology Pathology Spatial Open-Source multi-
Dimensional Integration) framework for the registration of radiology and pathology images.
RAPSODI relies on a three-step procedure that first reconstructs in three dimensions (3D) the
resected tissue using the serial whole-mount histopathology slices, then registers corresponding
histopathology and MRI slices, and finally maps the cancer outlines from the histopathology
slices onto MRI. We tested RAPSODI in a phantom study where we simulated various condi-
tions, e.g., tissue specimen rotation upon mounting on glass slides, tissue shrinkage during fixa-
tion, or imperfect slice-to-slice correspondences between histopathology and MRI images. Our
experiments showed that RAPSODI can reliably correct for rotations within ±15◦ and shrinkage
up to 10%. We also evaluated RAPSODI in 89 patients from two institutions that underwent
radical prostatectomy, yielding 543 histopathology slices that were registered to corresponding
T2 weighted MRI slices. We found a Dice similarity coefficient of 0.98±0.01 for the prostate,
prostate boundary Hausdorff distance of 1.71±0.48 mm, a urethra deviation of 2.91±1.25 mm,
and a landmark deviation of 2.88±0.70 mm between registered histopathology images and MRI.
Our robust framework successfully mapped the extent of disease from histopathology slices onto
MRI and created ground truth labels for characterizing prostate cancer on MRI. Our open-
source RAPSODI platform is available as a 3D Slicer plugin or as a stand-alone program and
can be downloaded from https://github.com/pimed/Slicer-RadPathFusion.
Keywords: radiology-pathology registration | prostate cancer | whole-mount histopathology |
radical prostatectomy | magnetic resonance imaging
1 Introduction
Despite advances in diagnosis and treatment, prostate cancer remains the second leading cause
of cancer death in American men [1]. Overdiagnosis of low-grade cancers that do not require
treatment and the underdiagnosis of aggressive cancers are still a concern [2], even after the changes
in the recommendation of prostate biopsy for elevated Prostate Specific Antigen (PSA). Magnetic
Resonance Imaging (MRI) can help address all of these problems [3]. When MRI is normal, up to
50% of men can safely avoid prostate biopsy, thereby reducing overdiagnosis of low-grade cancer and
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Publication Subject# Approach Additional Input
Dice
Coef.
Landmark
Error (mm)
Park 2008
[9] 2
3D reconstruction + affine
and TPS registration
block face picture,
ex vivo MRI NA
3-3.74
Chappelow
2011[10] 25
Feature Based Mutual In-
formation + BSpline
- NA NA
Ward 2012
[11] 13
2D Affine + TPS Regis-
tration
Strand-shaped
fiducials, Ex vivo
MRI
NA 1.1
Kalavagunta
2014 [12] 35 Local affine registration
Internal land-
marks, 3D Printed
Molds
0.99 1.54±0.64
Reynolds
2015 [13] 6
2D TPS registration + de-
formable registration
Control Points, ex
vivo MRI, section-
ing box
0.93 3.3
Li 2017 [14] 19
Multi-Scale Represen-
tation + deformable
registration
- 0.96±0.01 2.96±0.76
Losnegard
2018 [15] 12
3D histopathology recon-
struction, 3D affine and
deformable registration
- 0.94 5.4
Wu 2019
[16] 17
2D Rigid, TPS Regis-
tration (automatic land-
marks)
ex vivo MRI, 3D
printed molds
0.87±0.04 2.0±0.5
Rusu 2019
[17] 15
3D histopathology
reconstruction, 2D
Affine+Deformable
3D printed Molds 0.94±0.02 1.11±0.34
Table 1: Summary of previous approaches (not exhaustive). We excluded publications with <2
subjects [18], only synthetic data [19], or manually intensive approaches [20]. All summarized
methods require as input the in vivo pre-surgical T2 weighted MRI, digitized serial histopathology
images, and the segmentation of the prostate on MRI and histopathology images; Additional input
requirements are listed here; Abbreviations: TPS - Thin Plate Spline; NA - Not available
infectious complications of biopsy. However, this is only true when MRI is interpreted by world-
leading experts [4]. In practice, lack of widespread expertise and alarming levels of inter-reader
variation greatly reduce the potential of MRI to revolutionize prostate cancer diagnosis [5]. Both
false negatives and false positives, even when using the recommended PIRADS reporting system
[6], are very common and the vast majority of men who undergo MRI still undergo biopsy. Finally,
MRI has yet to supplant biopsy which is still required to confirm the presence and aggressiveness
of prostate cancer [7].
In men diagnosed with prostate cancer on biopsy, radical prostatectomy remains the most com-
mon treatment [8]. The resected prostate provides a unique opportunity to correlate pre-surgical
MRI with digitized histopathology images and map the exact extent of cancer from histopathol-
ogy images onto MRI. Developing a large dataset of prostatectomy cases where cancer and Gleason
grade is accurately mapped on MRI has two potentially transformative applications. First is helping
to improve existing MRI interpretation schemes that are still affected by many false positive and
false negative findings. Second, it may facilitate the development of machine learning methods to
identify prostate cancer on MRI by accurately labeling of cancer for model training and validation.
Although numerous approaches for the radiology-pathology registration in the prostate have
been introduced (see section “Prior Work“), these approaches have not been widely adopted and
have not been carefully tested by scientists outside the developer teams. Recent publications using
histopathology images as reference to improve MRI and automatically detect cancer [21, 22, 23, 24,
25] still use manual approaches to align the histopathology to MRI images, which are known to be
labor-intensive and subjective. The reduced adoption of previous methods is due to the challenges
associated with managing and registering the histopathology and Magnetic Resonance (MR) images,
the lack of open source release of existing methods, and the time constraints associated with running
these methods.
Specifically, the registration of histopathology images and prostate MRI has the following chal-
lenges. Histologic processing of the resected tissue causes artifacts, e.g., deformations, shrinkage,
and tissue ripping. Some of these artifacts (e.g., deformation and shrinking) can be corrected
through registration, while others (e.g. tissue ripping) are challenging to correct and may result
in discarding slices when such artifacts are major. Furthermore, our method and many others
[12, 13, 16] assume slice-to-slice correspondence between histopathology and MRI images, which
can be improved through the use of customized 3D printed molds based on pre-operative MRI [26].
However, this approach requires a change in clinical protocol that is not present in the vast majority
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of institutions performing radical prostatectomy. Finally, the acquired data is different between the
histopathology images and MRI. Histopathology images provide a discontinuous serial stack of 4µm
high-resolution colored images with a pixel size of 0.0005 mm separated by roughly 4 mm spaces,
while MRI has a typical resolution of 0.4×0.4×4 mm3.
Here, we introduce the RAPSODI (RAdiology Pathology Spatial Open-Source multi-Dimensional
Integration) framework for the registration of histopathology slices and pre-operative MRI. RAP-
SODI includes a dictionary-based data management system, a memory-efficient registration method-
ology and a Graphical User Interface Plugin to 3D Slicer [27]. Our registration approach relies on
the 3D reconstruction of the histopathology specimen to create a digital representation of the tissue
before gross sectioning. Next, RAPSODI registers corresponding histopathology and MRI slices.
Finally, the optimized transforms are applied to the cancer regions outlined on the histopathology
images to project those labels onto the pre-operative MRI.
We evaluated our methodology using a digital phantom study where we simulated various
conditions resulting from the histologic preparation of the excised tissue, e.g., rotation of the
tissue when mounting on the glass slide or shrinking of the tissue. Moreover, we tested RAP-
SODI in 89 prostate cancer patients that underwent radical prostatectomy from two institutions,
ours and a public cohort [28]. RAPSODI is open-source and can be downloaded from https:
//github.com/pimed/Slicer-RadPathFusion, while the phantom data is available at https://
github.com/pimed/rad-path-phantom.
1.1 Prior Work and Our Contribution
Although numerous automated approaches for the registration of radiology and histopathology
images have been developed, manual approaches are still employed, even in recent publications
[21, 22, 23, 24, 25]. Some manual or semi-automatic approaches utilize landmark-based registration
approaches, either alone [21, 22, 25] or in combination with automated registration steps [13, 22].
These approaches are labor-intensive and require the human operator to possess expertise in both
MRI and histopathology, and necessitate identification of corresponding landmarks on both modal-
ities. Other such approaches [26, 23] employ cognitive alignment in which a radiologist with the
help of a pathologist directly outlines the cancer region on MRI considering the histopathology
images as reference. Such methods are tedious to apply and may be prone to underestimating the
dimensions of the lesion [29] while MRI invisible lesions are hard if not impossible to outline and
thereby they are often omitted from follow-up analysis. A few approaches use interactive image
transformations [20], in which a user indicate scaling, rotations and translations to be applied to
the images. Such approaches are also tedious to utilize and require extensive knowledge in both
radiology and pathology of the prostate.
The automated registration of histopathology images with pre-surgical prostate MRI has been
performed in proof-of-concept studies, which usually only include a small number of subjects, often
< 20 (Table 1). Most approaches assume a slice-to-slice correspondence between the histopathology
images and T2 weighted (T2w) MRI slices. Some partial correspondence commonly results from
the gross sectioning of the prostate in histologic preparation which is done perpendicular to the
urethra. Yet, more advanced methods have been introduced to enforce such correspondences. For
example, three dimensional (3D) printed patient-specific molds [26] have been used [12, 13, 16]
to help preserve the correspondences during tissue sectioning. Some studies additionally included
blockface picture [9], ex vivo MRI [13, 16, 9, 11] or external fiducials [11] to help improve the
accuracy of the registration. Yet, these approaches required modifications of the clinical protocols
usually resulting in only a small number of subjects to be recruited for such research studies.
Once correspondences between the histopathology images and T2w MRI are identified, their
registration can still be challenging, partially due to the artifacts induced by the tissue preparation.
Textural features [10, 14] have been proposed, yet they may be cumbersome to use due to the high-
dimensional scoring function optimization and the choice of textural features. Other approaches
rely solely on image intensity to drive the deformable alignment [15, 17], but require accurate affine
alignment prior to the deformable registration.
Previous work in the lung [30, 31], breast [32] or prostate [15, 17], has relied on approaches
that reconstruct the sequential histopathology slices and created a 3D volume representing the
histopathology specimen prior to sectioning, which facilitates the spatial registration with the 3D
volumetric MRI and alleviates the need for slice correspondences. However, these methods are prone
to overfitting the histopathology reconstruction due to the large number of degrees of freedom and
may suffer from partial volume effects due to the missing data associated with thick MRI slices and
the histopathology slice spacing.
Our approach makes the following contributions: 1) Our registration methodology combines a
3D reconstruction of the histopathology specimen with 2D affine and deformable registration of
corresponding histopathology and MRI slices and was optimized for an accurate alignment, 2) Our
approach was tested in a digital phantom where the ground truth is known as well as in the largest
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Cohort C1: Internal Cohort C2: Public [28]
Variable MRI Pathology MRI Pathology
Manufacturer:
Coil type GE: Surface
- Siemens: En-
dorectal
-
Sequence/Data
Type
T2w whole-mount T2w pseudo-wholemount
Acquisition TR: [3.9, 6.3]; H&E TR: [3.7, 7.0]; H&E
Characteristics TE: [122, 130] TE: [107]
Number of Pa-
tients/Slices 74/1994 74/478 16/430 16/65
Matrix Size K,L ∈ [256, 512]
M ∈ [24, 43]
W,H ∈
[1663,7556]
K,L = 320,
M ∈ [21, 31]
W,H ∈
[2368,6324]
Pixel Spacing
(mm) ∈ [0.27,0.94]
∈
{0.0081,0.0162} ∈ [0.41,0.43] 0.0072*
Distance Be-
tween Slices
(mm)
∈ [3,5.2]
Same as MRI
via 3D printed
mold
4 Free hand
Annotations
Prostate,
Anatomic Land-
marks
Prostate,
Anatomic
Landmarks,
Cancer
Prostate, Can-
cer, Urethra
Prostate, Ure-
thra, Cancer
Table 2: Data Summary: Abbreviations: T2-weighted MRI (T2w), Hematoxylin & Eosin (H&E),
Relaxation Time (TR) in seconds, Echo Time (TE) in milliseconds; MRI Matrix Size: K ×L×M ,
Histology Matrix Size: W×H, * estimated, pseudo-whole mount: quadrants were stitched together
cohort considered to date in a radiology-pathology registration study, and 3) To the best of our
knowledge, we are the first to release the source code for the registration of histopathology and
radiology images in the prostate, which is essential to test the reproducibility and robustness of the
approach while allowing the wide adaption.
Methods
Notations
Let M be the T2 weighted (T2w) MRI image, M : R3 → R and has a matrix size K × L ×M ,
where K, L and M represent the width, height and number of slices of the axial T2w MRI. Let H
be the stack of histopathology slices, H : R3 → R3, obtained by stacking 2D histopathology slices,
Hi : R2 → R3. The histopathology images are colored images, with Red, Green and Blue channels.
The volume H has W ×H ×D voxels with three components corresponding to the Red, Green and
Blue channels, where D ∈ [3, 9] represents the number of slices, while W and H are the width and
height of the histopathology images. The index i, is used to indicate either an axial slice within
the MRI volume or an image in the histopathology stack. MPr and HPr represent the prostate
segmentation on MRI and histopathology images, respectively.
Data Description
Our IRB approved study includesN1 = 73 subjects from Stanford Hospital (Cohort C1) andN2 = 16
patients from the "Prostate Fused MRI Pathology" collection, The Cancer Imaging Archive [28]
(Cohort C2) (Table 2). A subset of 15 subjects from cohort C1 was previously utilized in [17]. The
subjects in C1 had an MRI acquired between 2016-2019 prior to the radical prostatectomy, and
the excised prostate was submitted for histologic preparation to generate whole-mount sections.
The subjects in C2 (description available at https://wiki.cancerimagingarchive.net/display/
Public/Prostate+Fused-MRI-Pathology), underwent radical prostatectomy and had the prostate
sectioned in quadrants before being submitted for histology processing.
MRI: The MRI exams for the patients in cohort C1 were acquired using 3 Tesla scanners (MR750,
GE Healthcare, Waukesha, WI) with an external 32-channel body array coil without an endorectal
coil. The imaging protocol included T2 weighted MRI (T2w), diffusion weighted imaging (DWI) and
derived Apparent Diffusion Coefficient (ADC), and dynamic contrast-enhanced imaging sequences.
For the patients in Cohort C2 were acquired on a 3T scanner (Siemens) using an endorectal coil.
The public repository provides T2w MRI and dynamic contrast-enhanced MRI for these patients.
In this study, we utilized the Axial T2w MRI, which is acquired using a 2D Spin Echo protocol
(Table 2)
Histopathology: The cohort C1 patients, following resection, the prostate was fixed in formalin,
sectioned using a patient-specific 3D printed mold built based on the pre-surgical MRI to maintain
the correspondence of histopathology slices and T2w images, and embedded in paraffin. This process
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Figure 1: Summary of our approach. First, we align the serial histopathology slices relative to each
other to reconstruct the 3D histopathology volume. Second, we register the histopathology slices
relative to the T2w MRI using rigid, affine and deformable transforms. Finally, we map the extent
of cancer from the histopathology images onto the radiology images.
is now part of our clinical standard of care. The histopathology for the patients in cohort C2, was
cut without the use of 3D printed molds, but seeking gross sectioning perpendicular to the urethra.
Mounting of the 5µm thick tissue on the glass slide can result in a rotation of the histopathology
slice as well as mounting with either aligned or misaligned left-right orientation. To account for
this variability, an expert indicated the gross rotation angle and whether the slice requires left-right
flipping. The whole-mount slices in C1 and quadrants sections in C2 were stained using Hematoxylin
& Eosin (H&E) and were digitized at 20x magnification (pixel size 0.5 µm). Pseudo-whole mounts
were generated for the images in C2, by stitching adjacent quadrants as described in [33].
Labels: Our expert radiologist (PG) outlined the prostate on MRI, MPr, while our expert
pathologist (CK) outlined the prostate, HPr, and the cancer on the high-resolution scanned images
of the histopathology specimen. Two hundred fifty-seven matching anatomic landmarks were picked
on both histopathology and radiology images for a subset of 12 subjects, targeting 3 landmarks for
each corresponding pair of histopathology and MRI slices. Examples of anatomic landmarks include
benign prostate hyperplasia nodules, ejaculatory ducts, predominant glands, etc. The urethra was
outlined on 22 studies in cohort C1 and the 16 studies in cohort C2. Outlining the urethra on MRI
is relatively straightforward at the apex of the prostate, yet it becomes challenging towards the
base. Thereby, often urethra annotations are available on the MRI from the mid-gland to apex, but
lacking between the mid-gland and the prostate base. Slice correspondences between the MRI and
histopathology were identified by an expert urologist and a radiology-pathology registration expert
and validated by a multi-disciplinary team of radiologists, pathologists and urologists.
Radiology - Pathology Registration
Our approach is summarized in Figure 1 and described below:
Step 0) Pre-Processing: We applied the prostate masks,MPr andHPr ontoM andH, respectively,
to exclude the structures outside the prostate from image registration. The gross rotation
angles or left-right flipping was applied as well.
Step 1) 3D Histopathology Reconstruction: We registered Hi relative each other, to ensure their
3D consistency within the 3D reconstruction, H. We selected the middle slice Hi, i = M2 as
the first fixed image and registered Hi−1 to Hi, Hi−2 with Hi−1, etc, as well as Hi+1 to Hi,
Hi+2 with Hi+1, etc. With the exception of the middle slice, all histopathology images will
have a corresponding rigid transform following the registration with the adjacent slice T HRig.
Step 2) 2D Registration: We registeredMi with Hi, for ∀i ∈ [1, D], by optimizing rigid T MRig, affine
T MAff and deformable T MDef transforms using gradient-based approaches. The rigid and affine
registrations only use the prostate masks during the optimization and applied Sum of Square
Differences as scoring function. The deformable registration used Free-Form Deformations [34]
to optimize the Mattes Mutual Information computed based on the image intensities. We used
a multi-resolution pyramid with three layers (with shrinking factors 16, 8, and 4 respectively,
and a smoothing sigma of 4, 2, and 1 respectively). The affine transform optimization was
done using a gradient descent optimizer with a learning rate of 0.01 and 250-500 iterations
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per resolution layer, while, the deformable registration employed a LBFGSB optimizer with
10-50 iterations per resolution layer.
Step 3) Mapping Cancer onto MRI: A composite transform of T HRig, T MRig, T MAff and T MDef is applied
to deform the histopathology image as well as the cancer label and anatomic landmarks into
the coordinates of the T2w MRI.
Our approach was developed using the Insight Toolkit (ITK) [35]and its Simple ITK API in
python. The approach is available as a 3D Slicer python plugin [27] (Figure 2) or as a stand-alone
application to be run in batch mode. RAPSODI can be downloaded from https://github.com/
pimed/Slicer-RadPathFusion. We measured the performance of the approach on an Intel i7-8700
CPU, 3.70GHz, 64GB Memory Computer.
Figure 2: Slicer Interface
Digital Phantom for Radiology-Pathology Registration
We created a digital phantom to assess the quality of the alignment during the development of
RAPSODI and to evaluate its performance when ground truth exists. The phantom is used to
simulate artifacts known to affect the histopathology sample. We constructed the phantom by
first outlining different prostatic regions, peripheral zone, cancer, and urethra in a 3D T2w MRI
(Figures 3a-c). Then, we synthesized the phantom T2 MRI by filling the segmented regions with
the average intensities from the input T2 image (Figure 3d). Moreover, we created the pathology
phantom based on the histopathology images already registered to the T2w MRI (data not shown),
by averaging their color intensities within the segmented regions (Figures 3e-f). Our simulations
included Gaussian noise on both the MRI and histopathology phantom slices.
Using the T2w and pathology phantom, we tested three conditions: 1) the influence of the rota-
tion angle when mounting the tissue slice on the glass slide, 2) the influence of shrinkage caused by
fixation of the tissue during histology processing, and 3) the influence of imperfect slice correspon-
dences between the MRI and histopathology slices, e.g., Figures 3d-e have a perfect correspondence,
while Figures 3d-f are 2mm apart from each other.
To evaluate RAPSODI, we used one or multiple conditions and evaluated different quantitative
metrics. Ten experiments were run for each condition to assess the mean and variance in performance
of RAPSODI. When a random rotation of r was assigned to the histopathology phantom, it resulted
in applying a random angle ranging between −r and r to each slide and running 10 experiments with
different noise and random angle conditions. When rotations were applied alone, no translation or
scaling were applied. When a shrinkage factor s is applied, all histopathology slices are shrunk by
s relative to their original appearance. Moreover, along with shrinking the images, we also apply
a random translation of as much as 5% relative to the entire image in either x or y directions.
Thereby, the experiments that include rotation and shrinkage also include random translation, and
when combined with the imperfect slice correspondences represent the closest condition to the real
data.
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(a) (b) (c)
(d) (e) (f)
Figure 3: Radiology-Pathology Digital Phantom. The expert annotation of the prostate (orange),
peripheral zone (blue), urethra (yellow) and cancer(red) on 3D T2 MRI, shown in the (a) Axial; (b)
Sagittal; (c) 3D Views, were used to create a digital phantom of the prostate: (d) Slice in the MRI
phantom, (e) Corresponding slice in the Pathology phantom, and (f) imperfect corresponding slice
that is 2mm apart from (d) in the sagittal plane (yellow and orange are the outlines of the urethra
and prostate(d)). Note the urethra misalignment (inset) and the border differences (arrow). Color
legend: yellow - urethra, orange - prostate, blue - peripheral zone, cancer - red
Quantitative Evaluation
The accuracy of the radiology-histopathology registration was evaluated using the Dice similarity
coefficient, which assesses the overlap of the prostate outlined on T2w MRI and the outline of the
prostate from the histopathology reconstruction:
Dice(H,M) = 1
D
D∑
i=1
2× |HPri ∩MPri |
|HPri |+ |MPri |
(1)
where D is the number of slices in the histopathology specimen, HPri represents the slice i
in the prostate segmentation on histopathology, while MPri represents the slice i in the prostate
segmentation on MRI.
Additionally, we evaluated the Hausdorff distance between the prostate boundary, to asses how
far the boundary is after performing the registration:
HausdorffPr(H,M) = max{suph∈HPr infm∈MPrd(H,M),
supm∈MPr infh∈HPrd(H,M)}
(2)
where sup represents the supremum operator and inf represents the infimum operators.
Moreover, we evaluated the landmark distance:
Dist(LH ,LM ) = 1
X
X∑
j=1
|LHj ,LMj |2 (3)
where |.|2 represents the Euclidean distance of the center of mass of the j landmark LHj on
histopathology and center of mass of the j landmark LMj on MRI, while X represents the number
of landmarks. Similarly, we computed the urethra distances, using per-slice correspondences, and
slices where the urethra was visible on both MRI and histopathology slices.
Results
Phantom Study
The phantom study is used to assess the average performance and variability of RAPSODI under
conditions known to affect the tissue during the histopathology preparation. We ran our registration
7
0 10 20 30 40
Rotation Angle ( )
0.95
0.96
0.97
0.98
0.99
1.00
D
ic
e 
Co
ef
fic
ie
nt
(a)
0 10 20 30 40
Rotation Angle ( )
0.95
0.96
0.97
0.98
0.99
1.00
D
ic
e 
Co
ef
fic
ie
nt
(b)
0.0 0.1 0.2 0.3
Shrinking Factor
0.95
0.96
0.97
0.98
0.99
1.00
D
ic
e 
Co
ef
fic
ie
nt
(c)
0.0 0.1 0.2 0.3
Shrinking Factor
0.95
0.96
0.97
0.98
0.99
1.00
D
ic
e 
Co
ef
fic
ie
nt
(d)
0 10 20 30 40
Rotation Angle ( )
0
1
2
3
4
5
6
U
re
th
ra
 D
ev
ia
ti
on
 
(P
ix
el
s)
(e)
0 10 20 30 40
Rotation Angle ( )
0
1
2
3
4
5
6
U
re
th
ra
 D
ev
ia
ti
on
 
(P
ix
el
s)
(f)
0.0 0.1 0.2 0.3
Shrinking Factor
0
1
2
3
4
5
6
U
re
th
ra
 D
ev
ia
ti
on
 
(P
ix
el
s)
(g)
0.0 0.1 0.2 0.3
Shrinking Factor
0
1
2
3
4
5
6
U
re
th
ra
 D
ev
ia
ti
on
 
(P
ix
el
s)
(h)
0 10 20 30 40
Rotation Angle ( )
0
1
2
3
4
5
6
7
8
H
au
ss
do
rf
 D
is
ta
nc
e 
(P
ix
el
s)
(i)
0 10 20 30 40
Rotation Angle ( )
0
1
2
3
4
5
6
7
8
H
au
ss
do
rf
 D
is
ta
nc
e 
(P
ix
el
s)
(j)
0.0 0.1 0.2 0.3
Shrinking Factor
0
1
2
3
4
5
6
7
8
H
au
ss
do
rf
 D
is
ta
nc
e 
(P
ix
el
s)
(k)
0.0 0.1 0.2 0.3
Shrinking Factor
0
1
2
3
4
5
6
7
8
H
au
ss
do
rf
 D
is
ta
nc
e 
(P
ix
el
s)
(l)
Figure 4: RAPSODI results for the registration of histopathology and T2w MRI slices in the digital
phantom in terms of (a-d) Dice Coefficient, (e-h) Urethra Deviation, (i-l) Hausdorff Distance. (a,e,i)
Effect of the rotation (X-axis) on the quantitative metrics when no shrinkage is applied; (b,f,j)
Constant 20% shrinkage is applied along with a randomly assigned rotations; (c,g,k) Effect of tissue
shrinkage, while no rotation was applied; (d,h,l) A rotation angle of 20◦ is applied along with the
shrinkage.
approach for 480 different conditions, to estimate the trends of the evaluation metrics as well as to
their variations. Figure 4 summarizes our results in which we tested the effect of the rotation of
histopathology slices while mounting on glass slide (range: 0-40◦), and the effect of shrinkage (range:
0-30%) when perfect slice correspondences exist between the histopathology and the MRI images
in the phantom. Our approach is able to perfectly recover rotation angles ranging between 0-20◦ or
shrinkage of 0-10% when applied alone (Figure 4), indicated by the perfect˜1 dice coefficient and the
sub-pixel error. When combined, either using 20% shrinkage and random rotation (Figures 4b,f,j)
or using 20◦ rotation and shrinkage (Figures 4d,h,l), sub-pixel accuracy was observed for angles
ranging between 0-15◦ or shrinkage of 0-5%. Beyond these conditions, RAPSODI is still able to
recover induced rotation and shrinkage, yet with some misalignment as the initial starting conditions
are far from the correct solution.
Moreover, the limitations of the registration may be observed when perfect correspondences are
lacking between the histopathology and MRI slices (Figure 5). Not surprising, the landmark and
prostate border deviation are as large as ∼ 4 pixels (1.6 mm), as these features are not perfectly
matching. Yet we can observe the relative stability of the approach for rotations ranging 0-30◦
and all tested shrinkage factors ranging between 0-30%, as the induced rotation and shrinkage are
properly recovered.
Qualitative Results
We applied RAPSODI to register the histopathology slices and T2w MRI in our radical prostatec-
tomy cohorts of 89 patients. Figure 6 shows the qualitative results for a subject in cohort C1 that
had a Dice Coefficient of 0.98 and a Hausdorff distance of 1.75 mm of the prostate border (∼ 4
pixels). Figure 7 shows the same slice as Figures 6 Raw 2, with the histopathology slice shown with
progressive transparency from right-left (Figure 7a) and left to right (Figure 7b) to emphasize the
alignment of the two modalities. The qualitative and quantitative evaluation suggest that a good
alignment was obtained for this subject.
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Figure 5: RAPSODI results for the registration of histopathology and T2w MRI slices in the digital
phantom where an imperfect correspondence between the histopathology and T2w MRI slices exist
(they are 2 mm apart from each other in the Sagittal and coronal planes, e.g., Figure 3d,f): (a-b)
Dice Coefficient; (c-d) Urethra Deviation; (e-f) Hausdorff Distance. (a,c,e) Experiment where only
the rotation angle was varied between 0-40◦; (b,d,f) The histopathology images were shrunk by
0-30% of the original size.
The accurate registration allowed us to map the extent of two cancer foci with different Gleason
groups (Figure 7, blue - Gleason group 2; red - Gleason Group 3). Although the higher grade
cancer is visible on MRI, its MRI visible borders are smaller than the histopathology projected
lesion, confirming previous work showing that MRI underestimates actual tumor size [29]. The
fusion enabled the mapping of the Gleason Group 2 cancer, which is not clearly visible on MRI,
and would have been otherwise difficult to outline on MRI.
Figure 8 shows a subject in cohort C2 for which the alignment of the prostate achieved a Dice
coefficient of 0.98 and a Hausdorff distance of 2.50 mm on the prostate boundary. As for the results
in Figures 6-7, the results for this subject are average and not outline. The five histopathology
images (Figure 8 Column 1) were registered with the MRI (Figure 8 Column 2), and the cancer
outline (red) was mapped onto MRI (Figure 8 Columns 3-4). The public dataset includes the
cancer annotation (blue) for this subject, which was obtained using a landmark-based registration
[33]. The cancer annotations obtained via RAPSODI overlaps well with the labels provided by the
dataset authors, with a dice overlap of 0.58 and a Hausdorff Distance of 2.71 mm. The relatively
low overlap indicated by the dice coefficient may be accounted by the relatively small size of the
tumor, and the misalignment of the regions in the apex slice (Figure 8 Row 1).
Quantitative Results
An improvement in the alignment of the histopathology images and the T2w MRI can be observed
across the different steps of our framework (Figure 9). Statistically significant differences in Dice
coefficients and Hausdorff distances were found between the input and the results of the registration
performed using RAPSODI(Mann-Whitney test is statistically significant for α < 0.05). These
statistically significant differences were observed both between the input and the affine registration in
step 2 as well as between the affine registration and the deformable registration in step 2, suggesting
that both affine and deformable registrations are required to facilitate an accurate alignment. The
urethra (Figures 9c,f) and the landmark deviations failed to show a clear trend, but we observe
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Figure 6: Qualitative results showing the registration for all the histopathology slices from apex to
base in one subject in Cohort C1. (Left) Histopathology slices with cancer outlines (red); (Mid-
dle) Corresponding T2w MRI with cancer outlines obtained via RAPSODI; (Right) overlay of the
registered histopathology images and corresponding T2w MRI with histopathology images shown
transparent.
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Figure 7: Overlay of registered histopathology and T2w images (same as slice as shown in Figure 6
Raw 2). Histopathology shown with a progressive transparency from (a) right-left, and (d) left-right
with cancer outlines (red – Gleason Group 3, blue-Gleason group 2).
Cohort DiceProstate
Haussdorff Dis-
tance (mm)
Urethra Devia-
tion (mm)
Landmarks Devia-
tion (mm) Dice Cancer
C1 0.98±0.01 1.79±0.45 2.74±0.82 2.88±0.70 -
C2 0.98±0.01 1.37±0.47 3.14±1.71 - 0.53±0.18
All 0.98±0.01 1.71±0.48 2.91±1.25 2.88±0.70 0.53±0.18
Table 3: Quantitative results for the two cohorts and aggregated or all subjects in our study.
a moderate decrease of landmark deviation between the input, 2.94±0.54 mm, and after applying
RAPSODI, 2.88±0.7 mm, however, these differences were not statistically significant..
The comparison of results from cohorts C1 and C2 indicated that RAPSODI produces consistent
results, with Dice coefficients on the prostate border of 0.98, and Hausdorff distances averaging 1.36-
1.78 mm (Table 3). The subjects in cohort C2 have MRIs acquired using an endorectal coil which
causes larger deformations of the prostate. Thereby, the input data and affine registration results
show worse alignment in cohort C2 compared to cohort C1. However, similar metrics are evaluated
after the deformable registration in RAPSODI, suggesting that our approach generalizes even for
larger deformations, as those induced by an endorectal coil.
Additional evaluation was possible in cohort C2, since the authors of the dataset [28] have
provided the mapped cancer obtained via landmark-based registration [33]. Thereby, we compared
the mapped cancer from RAPSODI with those provided by the dataset authors, and we observed
a dice coefficient of 0.53 ± 0.18 and deviation computed on the center of mass of 2.71 ± 1.31 mm.
The relatively reduced alignment of the cancer labels may be attributed to the general misalignment
error, which is within 3 mm inside the prostate and 2 mm on the prostate border. This misalignment
can have a significant effect on the value of the overlap evaluated via Dice coefficient for regions of
small size, such as the cancer.
Due to the use of stitched histopathology images, and of endorectal coil MRI, larger deformations
needed to be recovered when aligning the histopathology images to MRI in the patients in cohort
C2. The pseudo-whole mounts can have stitching artifacts that are absent in the whole-mount
histopathology images. For example, the stitched pseudo-whole mount images are elongated in the
anterior-posterior direction, e.g. slice C1234 of patient aaa0054. The affine parameters, i.e. scales,
of the registration were relaxed, in order to enable the recovery of such large anisotropic stretching.
Such modifications were only required for processing two patients, aaa0054 and aaa0072.
In order to identify the optimal set of steps in our registration, we tested multiple combinations
of processing steps (data not shown) for the subjects in cohort C1, e.g., skipping step 1 (histopathol-
ogy reconstruction), or applying step 2 without performing the deformable registration. We found
that the RAPSODI approach (Histopathology reconstruction followed by 2D affine and deformable
transforms) achieves the highest accuracy, showing the highest Dice coefficients and lowest Haus-
dorff distances and landmark deviations compared to approaches where we skipped step 1 or the
deformable registration in step 2.
Discussion
Here, we introduced the RAPSODI platform that enables the registration of histopathology and
MR images in the prostate. RAPSODI first reconstructs the histopathology volume using pair-
wise registration starting from the mid-gland slices towards the apex and base slices, respectively,
followed by a slice-to-slice alignment between the corresponding histopathology and T2w images.
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Figure 8: Qualitative results showing the registration for all the histopathology slices from apex
to base in subject aaa0059 from Cohort C2. (Column 1) Histopathology slices with cancer out-
lines (red); (Column 2) Overlay of the registered histopathology and corresponding T2w MRI with
histopathology images shown transparent. (Column 3) Corresponding T2w MRI with cancer out-
lines obtained via RAPSODI (red) or provided by dataset authors (blue); (Column 4) Closeup into
the cancer region with outlines shown at the same resolution as the T2w MRI.
The reconstruction ensures the consistent stacking of the histopathology slices relative to each other,
independent of the MRI, which results in a better initialization of the histopathology slices in the
registration with the MRI images.
We first evaluated RAPSODI in a digital phantom and showed that our framework can recover
the rotation angles of the histopathology slices resulting from the slide mounting on glass slides
when these angles are within 0-15◦ from the correct solution and with tissue shrinkage up to 10%.
Correcting for large rotation angles can be achieved prior to applying RAPSODI either by using
automated approaches, e.g., by aligning the major axis of the data [17], or via manual approaches
where the user indicates an angle, as was done in our study. The tissue shrinks during fixation with
a factor that is outside our control. The affine transform helps identify the shrinkage factor, yet
the accuracy of the registration declines as the initial conditions are further away from the optimal
solution. Registration errors are most apparent at the prostate apex, where the prostate size, shape
and textures are reduced.
RAPSODI successfully registered histopathology images with corresponding T2w MR images in
the 89 subjects (543 slices) achieving a prostate boundary error within 2 mm and an interior error
within 3 mm. Through the use of the prostate segmentation during the registration, we emphasize
the importance of the prostate border resulting in a better alignment compared to the interior
landmarks. Moreover, picking the landmarks used for evaluation can be challenging as we sought to
capture 3+ landmarks/slice, and the resolution of the MRI is relatively reduced due to the surface
coil acquisition.
We acknowledge the following limitations for our approach. Although the registration approach
is fully automated and does not require patient-specific parameterization for general cases without
unusual artifacts, similar to existing approaches, some manual interventions are needed to either
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Figure 9: Quantitative evaluation of RAPSODI; (a-c) Results for Cohort C1; (d-f) Results for
Cohort C2; (a,d) Dice Coefficients computed for the prostate and (b,e) Hausdorff distance of the
prostate border. (c,f) The urethra deviations. p-value for Mann-Whitney test; legend: ns-non
significant: 0.05 < p <= 1.00; ****: p <= 0.0001
segment the prostate on both MRI and histopathology images, to identify slice correspondences
between the histopathology and T2w MRI or to correct the gross rotation of the histopathology
slices. Unlike other approaches, RAPSODI does not require landmark selection, but only uses them
to evaluate the accuracy of registration.
The registration assumes that a slice-to-slice correspondence exists between the histopathology
and MR images. While this is improved by using 3D printed molds, slice misalignment is possible
due to the shrinking of the prostate during fixation and shifting in the mold during slicing. Such
misalignment is occasionally observed at the base and apex of the prostate. The digital phantom
allowed us to study the effect of such misalignment and showed that a perfect alignment cannot be
obtained in this situation (we observed a ∼4 pixels error) yet the induced shrinkage and rotations
are well recovered.
The registration runtime for our approach is 6-8 minutes which is limiting for a Graphical User
Interface execution, yet it is acceptable when running the approach in batch mode. We investigated
a computationally efficient method that skips Step 1 - reconstructing the histopathology, and runs
the registration at lower resolution. The fast approach run in 3.1 minutes and achieved a Dice
coefficient of 0.97±0.01, a Hausdorff distance of 2.23±0.66 mm, urethra deviation 2.81±0.73mm
and landmark deviation of 2.92±0.7 mm in a 66 patient subset from Cohort C1. Although the
results are slightly less accurate, the fast approach is 2-3 times faster, and is more suited to running
in a Graphical User Interface.
Although our study only includes 89 patients from two institutions, to date it represents the
largest study of this magnitude with data from multiple institutions, with MRI acquired either using
surface or endorectal coils, and the only study to evaluate the approach in a digital histopathology-
MRI prostate phantom. Compared to previous approaches outlined in Table 1, our quantitative
results place us close to the method by Kalavagunta et. al. [12] in terms of Dice similarity coefficient.
The latter approach relies on heavily annotated datasets that include the border of the transitional
zone and the peripheral zone as well as other landmarks. Such landmarks are used to drive the
registration at the interior of the prostate resulting in better landmark alignment, yet the approach
is labor-intensive and requires careful examination of the data to identify matching landmarks in
the pathology images and MRI, which is not trivial.
RAPSODI aims at registering the histopathology and MRI images with the sole goal of mapping
the extent and grade of cancer from histopathology images onto T2 weighted MRI, thus creating
careful and objective spatial labels on pre-operative MRI. Such mapping may help develop advanced
image analysis tools to reliably predict prostate cancer and its aggressiveness on MRI, help improve
current MRI interpretation schemes as well as help validate novel MRI protocols or other imaging
techniques. Better imaging accompanied by better interpretation schemes can have great impact in
reducing overdiagnosis of low-grade cancers, the underdiagnosis of aggressive cancers, and infectious
complications of biopsy.
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Conclusion
Our radiology-pathology registration framework, RAPSODI, allowed the alignment of histopathol-
ogy slices and pre-surgical MRI, enabling the accurate mapping of the labels from histopathology
onto MRI. The reconstruction of the 3D histopathology specimen followed by 2D registration of cor-
responding histopathology and T2w MRI slices ensured a robust alignment that provides accurate
prostate cancer labels for MRI.
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